Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$13.89 - $15.04 $239,991 - $259,861
17,278 New
17,278 $239,000
Q2 2022

Aug 11, 2022

SELL
$13.12 - $15.03 $442,327 - $506,721
-33,714 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$13.54 - $15.35 $72,804 - $82,536
5,377 Added 18.98%
33,714 $483,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $373,198 - $464,726
28,337 New
28,337 $386,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.